Cibus elects Thomas Urban to board of directors
- Investing.com
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Cibus Inc (CBUS)
The Cibus share price today is 1.50 %REPORT_CURRENCY%, view NASDAQ CBUS stock exchange data. Track the latest Cibus share price with real-time updates on CBUS stock performance including market cap, day range, 52-week range and dividend yield. Access CBUS charts, earnings dates and analyst estimates to support your investment decisions.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.40
1.51
52 wk Range
1.09
4.19
CBUS is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.401.51
52 wk Range
1.094.19
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CBUS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
14.67
Upside
+877.78%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
- Cibus appoints Thomas Urban to board of directors
- Investing.com
- Form 424B5 Cibus Inc For: 26 March
- Investing.com
- Cibus elects Thomas Urban to board of directors
- Investing.com
- Cibus appoints Thomas Urban to board of directors
- Investing.com
- Form 424B5 Cibus Inc For: 26 March
- Investing.com
- Cibus prices public offering at $2.15 per share
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.
Cibus Inc Earnings Call Summary for Q4/2025
- Cibus raised $22.3M in Jan 2026, extending cash runway into late Q3 2026; targets annual net cash usage of $30M or less in 2026
- Q4 2025 net loss widened 23.6% to $31.9M vs. $25.8M year-ago, driven by increased royalty liability interest expenses
- Operating expenses cut ~$10M in 2025; R&D and SG&A reduced 24.2% and 25.0% respectively in Q4 through facility consolidation
- Stock rose 3.23% to $3.62 in aftermarket trading on investor optimism over cost-cutting measures and extended operational runway
- Rice program commercial expansion expected 2027 with potential $200M annual royalty opportunity; biofragrance scale production targeted late 2026
Last Updated: 18-03-2026, 03:04 am
Read Full TranscriptCompare CBUS to Peers and Sector
Metrics to compare | CBUS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCBUSPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.9x | −0.7x | −0.5x | |
PEG Ratio | −0.01 | −0.01 | 0.00 | |
Price/Book | 5.2x | 0.9x | 2.6x | |
Price / LTM Sales | 31.4x | 9.6x | 3.2x | |
Upside (Analyst Target) | - | 1,121.1% | 47.4% | |
Fair Value Upside | Unlock | 43.9% | 7.7% | Unlock |
Analyst Ratings
2 Buy
1 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 14.67
(+877.78% Upside)
Earnings
Latest Release
17-03-2026
EPS / Forecast
-0.59 / -0.23
Revenue / Forecast
1.06M / --
FAQ
What Is the Cibus (CBUS) Share Price Today?
The Cibus share price today is 1.50 USD.
What is the current Cibus (CBUS) share price and day range?
As of 25-04-2026, the Cibus share price is 1.50 USD, with a previous close of 1.45 USD. The share price has ranged from 1.40 to 1.51 USD today, while the 52-week range spans from 1.09 to 4.19 USD.
What Is the Cibus Market Cap?
As of today, Cibus market cap is 114.42M.
What Is the Cibus (CBUS) Share Price Target?
The average 12-month share price target for Cibus is 14.67 USD, with a high estimate of 25 USD and a low estimate of 3 USD. 2 analysts recommend buying, while 0 suggest selling, with an overall rating of Buy and +877.78% Upside potential.
What Is Cibus's Earnings Per Share (TTM)?
The Cibus EPS (TTM) is -2.78.
When Is the Next Cibus Earnings Date?
Cibus will release its next earnings report on 13-11-2025.
From a Technical Analysis Perspective, Is CBUS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does Cibus Trade On?
Cibus is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Cibus?
The stock symbol for Cibus is "CBUS."
How Many Times Has Cibus Stock Split?
Cibus has split 0 times.
How Many Employees Does Cibus Have?
Cibus has 118 employees.
What Is the CBUS Premarket Price?
CBUS's last pre-market stock price is 1.53 USD. The pre-market share volume is 70.00, and the stock has changed by 0.08 USD, or 5.52%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.